Revised SPC: Epanutin (phenytoin) Infatabs 50 mg chewable tablets and 30mg/5ml oral Suspension

SPCs revised to warn that angioedema has been reported in patients treated with phenytoin and fosphenytoin and treatment should be discontinued immediately if symptoms of angioedema, such as facial, perioral, or upper airway swelling occur.


electronic Medicines compendium